BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8820578)

  • 1. Assessing chemicals for estrogenic/hormone-disrupting properties: lessons from carcinogenicity assessment.
    Ashby J
    Environ Health Perspect; 1996 Feb; 104(2):132-4. PubMed ID: 8820578
    [No Abstract]   [Full Text] [Related]  

  • 2. Environmental estrogens.
    Wolff MS
    Environ Health Perspect; 1995 Sep; 103(9):784-5. PubMed ID: 7498080
    [No Abstract]   [Full Text] [Related]  

  • 3. [Value of animal experiments in risk assessment in the human].
    Zbinden G
    Offentl Gesundheitswes; 1990 May; 52 Suppl 1():16-8. PubMed ID: 2141676
    [No Abstract]   [Full Text] [Related]  

  • 4. Risk assessments of low-level exposures.
    Smith SJ; Chen AT; Caudill SP; Wetterhall SF; Sever LE
    Science; 1995 Feb; 267(5198):603-4. PubMed ID: 7839131
    [No Abstract]   [Full Text] [Related]  

  • 5. Estimating the extent of the health hazard posed by high-production volume chemicals.
    Cunningham AR; Rosenkranz HS
    Environ Health Perspect; 2001 Sep; 109(9):953-6. PubMed ID: 11673126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing environmental chemicals for estrogenicity using a combination of in vitro and in vivo assays.
    Shelby MD; Newbold RR; Tully DB; Chae K; Davis VL
    Environ Health Perspect; 1996 Dec; 104(12):1296-300. PubMed ID: 9118870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The contribution of the mouse in hazard identification studies.
    Maronpot RR; Boorman GA
    Toxicol Pathol; 1996; 24(6):726-31. PubMed ID: 8994301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re: Implementation of WHO Guidelines on Disclosure of Interest by members of WHO Expert Panels.
    Axelson O; Castleman B; Epstein S; Franco G; Giannasi F; Grandjean P; Greenberg M; Hooper K; Huff J; Jacobson M; Joshi TK; Kulkarni GK; LaDou J; Mazaheri M; Mekonnen Y; Melnick R; Mirabelli D; Ofrin R; Partanen T; Pott F; Sass J; Soskolne CL; Suplido ML; Terracini B; Tomatis L; Ungvary G; Watterson A; Wesseling C; Yassi A
    Int J Occup Environ Health; 2002; 8(3):271-3. PubMed ID: 12358082
    [No Abstract]   [Full Text] [Related]  

  • 9. Animal carcinogenicity studies: implications for the REACH system.
    Knight A; Bailey J; Balcombe J
    Altern Lab Anim; 2006 Mar; 34 Suppl 1():139-47. PubMed ID: 16555967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Application of quantum-chemical methods to prediction of the carcinogenicity of chemical substances].
    Zholdikova ZI; Kharchevnikova NV
    Vestn Ross Akad Med Nauk; 2006; (4):46-54. PubMed ID: 16889356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hazard and risk assessment of chemical mixtures using the toxic equivalency factor approach.
    Safe SH
    Environ Health Perspect; 1998 Aug; 106 Suppl 4(Suppl 4):1051-8. PubMed ID: 9703492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re the article "Incorporating potency into the EU classification for carcinogenicity and reproductive toxicity" by Hennes C et al. (Regulatory toxicology and Pharmacology, 70 (1024), 457-67).
    Kelsey JR; Davison P
    Regul Toxicol Pharmacol; 2015 Aug; 72(3):702. PubMed ID: 25797335
    [No Abstract]   [Full Text] [Related]  

  • 13. New clues on carcinogenicity-related substructures derived from mining two large datasets of chemical compounds.
    Golbamaki A; Benfenati E; Golbamaki N; Manganaro A; Merdivan E; Roncaglioni A; Gini G
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2016 Apr; 34(2):97-113. PubMed ID: 26986491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ten most prevalent hazardous chemicals in New Jersey.
    Marcus S; Ruck B
    N J Med; 2004 Sep; 101(9 Suppl):34-43; quiz 43-4. PubMed ID: 15497733
    [No Abstract]   [Full Text] [Related]  

  • 15. Reducing exposure to synthetic chemicals can fight diabetes.
    Nurs Stand; 2016 Nov; 31(11):17. PubMed ID: 27848434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitellogenesis as a biomarker for estrogenic contamination of the aquatic environment.
    Sumpter JP; Jobling S
    Environ Health Perspect; 1995 Oct; 103 Suppl 7(Suppl 7):173-8. PubMed ID: 8593867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of different computerized classification methods for predicting carcinogenicity from short-term test results.
    Benigni R; Pellizzone G; Giuliani A
    J Toxicol Environ Health; 1989; 28(4):427-44. PubMed ID: 2593175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Risk assessment of known and new chemicals].
    Dawidek-Pietryka K; Dudka J
    Med Pr; 2002; 53(2):145-9. PubMed ID: 12116905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporating potency into EU classification for carcinogenicity and reproductive toxicity.
    Hennes C; Batke M; Bomann W; Duhayon S; Kosemund K; Politano V; Stinchcombe S; Doe J
    Regul Toxicol Pharmacol; 2014 Nov; 70(2):457-67. PubMed ID: 25092129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relevance of mechanistic data to the interpretation and extrapolation to humans of rodent carcinogenicity data.
    Ashby J
    Environ Health Perspect; 1997 Sep; 105(9):902-3. PubMed ID: 9341097
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.